SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-279957
Filing Date
2011-10-25
Accepted
2011-10-25 13:22:01
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d226890d10q.htm 10-Q 636366
2 AMENDMENT TO RESTRICTED STOCK AGREEMENT d226890dex104.htm EX-10.4 5137
3 SECTION 302 CEO CERTIFICATION d226890dex311.htm EX-31.1 7372
4 SECTION 302 CFO CERTIFICATION d226890dex312.htm EX-31.2 7716
5 SECTION 906 CEO AND CFO CERTIFICATION d226890dex32.htm EX-32 7055
  Complete submission text file 0001193125-11-279957.txt   2022689

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctic-20110930.xml EX-101.INS 203854
7 XBRL TAXONOMY EXTENSION SCHEMA ctic-20110930.xsd EX-101.SCH 16845
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20110930_cal.xml EX-101.CAL 35651
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20110930_def.xml EX-101.DEF 86905
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20110930_lab.xml EX-101.LAB 98772
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20110930_pre.xml EX-101.PRE 93392
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 111156259
SIC: 2834 Pharmaceutical Preparations